TABLE I.
Parameter | Points |
---|---|
EBV load (PCR) <5,000 copies/ml | 1 |
EBV load (PCR) >5,000 copies/ml | 2 |
Duration of EBV viremia <1 month | 1 |
Duration of EBV viremia >1 month | 2 |
Presence of EBV in tissues | 2 |
Evidence (history, serologies, PCR) of exposure to other virus associated with HLH | −1 |
Alternative etiologies for HLH | −1 |
EBV, Epstein–Barr virus; HLH, hemophagocytic lymphohistiocytosis; PCR, polymerase chain reaction.
Determination of EBV infection as the primary process causing HLH: definite: 6 points; probable: 3–5 points; possible: 1–2 points.
Low levels of EBV viremia were defined as EBV titers <5,000 copies/ml based on the reviewed literature of previous EBV-HLH cases.
High levels of EBV viremia were defined as EBV titers >5,000 copies/ml based on the reviewed literature of previous EBV-HLH cases.
Short duration of documented EBV viremia was defined as <1 month based on the reviewed literature of previous EBV-HLH cases.
Prolonged duration of documented EBV viremia was defined as >1 month based on the reviewed literature of previous EBV-HLH cases.
Alternative etiologies for HLH may include presence of other factors well known to be associated with HLH, such as other viral, fungal infection, immunodeficiency.